tradingkey.logo

Oscar Health Inc <OSCR.N> expected to post a loss of 59 cents a share - Earnings Preview

ReutersJan 31, 2025 9:27 PM
  • Oscar Health Inc OSCR.N, OSCR.K is expected to show a rise in quarterly revenue when it reports results on February 4 for the period ending December 31 2024

  • The New York City-based company is expected to report a 72.9% increase in revenue to $2.475 billion from $1.43 billion a year ago, according to the mean estimate from 7 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Oscar Health Inc is for a loss of 59 cents per share.

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 5 "strong buy" or "buy," 2 "hold" and 2 "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Oscar Health Inc is $19.00​, above​ its last closing price of $17.30. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Sep. 30 2024

-0.18

-0.17

-0.22

Missed

-28.3

Jun. 30 2024

0.17

0.16

0.20

Beat

23.7

Mar. 31 2024

0.27

0.27

0.62

Beat

127.9​

Dec. 31 2023

-0.73

-0.72

-0.66

Beat

8.7

​​Sep. 30 2023

-0.47

-0.47

-0.29

Beat

38.6

Jun. 30 2023

-0.22

-0.23

-0.07

Beat

69.6​

Mar. 31 2023

-0.04

-0.05

-0.18

Missed

-254.7

Dec. 31 2022

-1.09

-1.16

-1.05

Beat

9.5

This summary was machine generated January 31 at 21:27 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI